SKEL fjárfestingafélag hf.: Amendment to the financial
The audit of SKEL’s financial statements for the year 2022, which has not been finalized, has resulted in a change of
Globe Newswire5-02-2023, 01:16
Boehringer’s zongertinib shows encouraging efficacy and tolerability profile in previously treated HER2 mutated lung cancer patients 9-09-2024, 22:45